| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT07703137 NAD Supplementation in Parkinson's Disease |
Enrolling by invitation only |
| 2026-08-13 | NCT07703137 NAD Supplementation in Parkinson's Disease |
date change Primary completion pushed: 2027-06 -> 2027-07 |
| 2026-08-13 | NCT07703137 NAD Supplementation in Parkinson's Disease |
date change Completion pushed: 2027-06 -> 2027-07 |
| 2026-08-12 | NCT05230732 Neuromodulation of Inflammation and Endothelial Function |
date change Primary completion pushed: 2026-02-27 -> 2027-02-27 |
| 2026-08-12 | NCT05230732 Neuromodulation of Inflammation and Endothelial Function |
date change Completion pushed: 2026-02-27 -> 2027-02-27 |
| 2026-08-02 | NCT05176379 Endothelial Derived Hyperpolarization Factor and Vascular Control |
overall status: Recruiting → Unknown |
| 2026-07-31 | NCT04928508 Advanced or Recurrent Solid Tumors Treated With SHetA2 |
date change Primary completion pushed: 2026-05 -> 2026-09 |
| 2026-07-31 | NCT03526432 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer |
date change Primary completion pushed: 2026-06-30 -> 2026-08-31 |
| 2026-07-31 | NCT06671730 Self-Determination Theory-informed Occupational Therapy Program to Increase Physical… |
Enrollment closed, study ongoing |
| 2026-07-31 | NCT06671730 Self-Determination Theory-informed Occupational Therapy Program to Increase Physical… |
Enrollment increased: 38 -> 99 participants |
| 2026-07-31 | NCT06671730 Self-Determination Theory-informed Occupational Therapy Program to Increase Physical… |
date change Primary completion moved earlier: 2026-05-31 -> 2025-10-03 |
| 2026-07-31 | NCT06671730 Self-Determination Theory-informed Occupational Therapy Program to Increase Physical… |
date change Completion pushed: 2026-05-31 -> 2026-11 |
| 2026-07-31 | NCT07238023 Promoting Active Living Among People With Metastatic Breast Cancer |
date change Primary completion pushed: 2026-06 -> 2026-09 |
| 2026-07-31 | NCT07238023 Promoting Active Living Among People With Metastatic Breast Cancer |
date change Completion pushed: 2026-06 -> 2026-12 |
| 2026-07-30 | NCT05043051 Autoimmune Basis for Postural Tachycardia Syndrome |
Trial completed |
| 2026-07-28 | NCT07701304 Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment |
Phase changed: not specified -> not applicable |
| 2026-07-25 | NCT04881630 Mobile Contingency Management for Smoking Cessation |
Trial completed |
| 2026-07-25 | NCT04881630 Mobile Contingency Management for Smoking Cessation |
date change Primary completion pushed: 2025-01-31 -> 2025-09-21 |
| 2026-07-25 | NCT04881630 Mobile Contingency Management for Smoking Cessation |
date change Completion moved earlier: 2026-09 -> 2025-09-21 |
| 2026-07-19 | NCT07701304 Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment |
date change Primary completion pushed: 2026-09-30 -> 2026-12-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-03 | NCT07742449 Feasibility and Acceptability of Empowered Relief for American Indians With Pain During… | Not Yet Recruiting | |
| 2026-07-30 | NCT07737795 Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer | Phase 2 | Not Yet Recruiting |
| 2026-07-29 | NCT07732686 Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06986993 | Impact of Semaglutide on Tobacco Use and Related Health Behaviors | Tobacco Use | Recruiting |
| NCT07200544 | Meloxicam in Mohs Micrographic Surgery | Postoperative Pain, Acute | Recruiting |
| NCT04248205 | Ketamine for Post-operative Analgesia in Hemorrhoidectomy | Hemorrhoids | Recruiting |
| NCT05483465 | The Effect of NAD Supplementation on Brain Vascular Health in Aging | Aging | Recruiting |
| NCT05587361 | Beta-Adrenergic Modulation of Drug Cue Reactivity | Tobacco Use Disorder | Recruiting |
| NCT04831398 | The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic… | Healthy | Active, Not Recruiting |
| Phase 3 | |||
| NCT05174052 | Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF) | Diabetes Mellitus | Recruiting |
| Phase 2/3 | |||
| NCT06821295 | Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing… | Alcohol Misuse | Recruiting |
| NCT06820034 | Empowering Cessation ACS South Region | Smoking Cessation | Recruiting |
| Phase 2 | |||
| NCT06516588 | tDCS for Post-Stroke Cognitive Impairment | Stroke | Recruiting |
| NCT05233228 | Mobile Health Technology for Personalized Tobacco Cessation Support in Laos | Cigarette Smoking | Recruiting |
| NCT05617716 | Spine Radiosurgery for Symptomatic Metastatic Neoplasms | Metastatic Neoplasm to the Spine | Recruiting |
| NCT05512208 | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib | Endometrioid Cancer | Recruiting |
| NCT07183319 | Circulating Tumor DNA Response In Urothelial Cancer | Urothelial Carcinoma | Recruiting |
| NCT07223541 | Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell… | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT06488781 | Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae… | Obesity in Pregnancy | Recruiting |
| NCT06296849 | Dyadic Financial Incentive Treatments for Dual Smoker Couples | Smoking, Cigarette | Recruiting |
| NCT04068753 | Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive… | Recurrent Cervix Cancer | Active, Not Recruiting |
| NCT07554131 | Evaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia | Refractory Amblyopia | Not Yet Recruiting |
| NCT04887558 | Mobile App for Smoking Cessation and Mental Health | Smoking Cessation | Active, Not Recruiting |
| NCT06660017 | Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse | Head and Neck Cancer | Not Yet Recruiting |
| NCT04373642 | "QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer | Head and Neck Cancer | Active, Not Recruiting |
| NCT06494150 | Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) | Low Grade Ovarian Serous Adenocarcinoma | Active, Not Recruiting |
| NCT06129604 | Pilot Window of Opportunity Trial (POET) | Colorectal Carcinoma (CRC) | Active, Not Recruiting |
| NCT07099638 | Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence… | Smoking Cessation | Not Yet Recruiting |